Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2000
06/28/2000EP1012151A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1012144A1 Method for producing (hetero)aromatic hydroxylamines
06/28/2000EP1012131A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
06/28/2000CN1258297A Process for producing beta-lactam derivs.
06/28/2000CN1258283A Cyclic diamine compounds and medicine contg. same
06/28/2000CN1053905C Oxadiazine derivs., their preparing process and use, intermediates for preparing same
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080756 Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
06/27/2000US6080755 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/22/2000WO2000035930A1 Vanadium compounds for treating cancer
06/22/2000WO2000035924A1 Camptothecin analogs and methods of preparation thereof
06/22/2000WO2000035918A1 Processes for the preparation of novel naphthyridine derivatives
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2355249A1 Protease inhibitors
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2353972A1 Processes for the preparation of novel naphthyridine derivatives
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2350730A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2348923A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347909A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2346933A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/21/2000EP1010731A2 Process for the preparation of highly chromatic perylene pigments
06/21/2000EP1010699A1 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
06/21/2000EP1010423A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
06/21/2000EP1009748A1 3-ALKYLPYRROLO 3,2-$i(c)]QUINOLINE DERIVATIVES
06/21/2000EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
06/21/2000EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
06/21/2000EP0638073B1 1-piperazino-1,2-dihydroindene derivatives
06/21/2000CN1257501A Process for preparing 6-0-monoesters of castanospermine
06/21/2000CN1257489A Substituted benzopyran derivatives for the treatment of inflammation
06/21/2000CN1257486A Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/21/2000CN1053668C Novel compound, process for preparing same and antitumor agent
06/20/2000US6077853 Inhibitors of farnesyl-protein transferase
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/20/2000US6077847 Administering a substituted indole compound to the patients for the treatment of a variety of sex-hormone related and other conditions in both men and women
06/20/2000US6077844 Pyrimidine derivatives and methods of making and using these derivatives
06/20/2000US6077843 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
06/20/2000US6077813 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
06/20/2000CA1341035C Macrocyclic polyaza compounds containing 5 or 6 membered rings, process for producing them and pharmaceutical media containing them.
06/20/2000CA1341034C Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators
06/15/2000WO2000034437A2 Inhibitors of prenyl-protein transferase
06/15/2000WO2000034286A2 Process for the preparation of pyrimidinone derivatives
06/15/2000WO2000034280A1 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
06/15/2000WO2000034279A1 1,4-diazabicyclo[3.2.2]nonane derivatives, their preparation and therapeutic application
06/15/2000WO2000034278A1 Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient
06/15/2000WO2000034277A1 Sulfonamide compounds and uses thereof as medicines
06/15/2000WO2000034265A2 Quinoline-indole antimicrobial agents
06/15/2000WO2000034263A1 Benzofuran derivatives, their preparation and use
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034242A1 Selective 5-ht6 receptor ligands
06/15/2000WO2000033839A1 Non-peptide antagonists of glp-1 receptor and methods of use
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000011000A3 New compounds
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000DE19857202A1 New benzimidazolyl amidine or nitrile compounds, useful as thrombin inhibitors or antithrombotic agents, for treating deep leg vein thrombosis
06/15/2000CA2353618A1 Benzofuran derivatives, their preparation and use
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352871A1 Sulfonamide compounds and uses thereof as medicines
06/15/2000CA2350887A1 Non-peptide antagonists of glp-1 receptor and methods of use
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000CA2319435A1 Triazolo derivatives and chemokine inhibitors containing the same as effective component
06/14/2000EP1007526A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
06/14/2000EP1007525A1 Aminometyl oxooxazolidinyl benzene derivatives
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP0525057B1 Antimicrobial quinolonyl lactams
06/14/2000CN1256693A 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity
06/13/2000US6075148 Carbamates and crop protection agents containing them
06/13/2000US6075037 Endothelin receptor antagonists
06/13/2000US6075036 Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075021 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
06/13/2000CA2085878C Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions
06/08/2000WO2000032649A1 Method of producing derivatized polymers
06/08/2000WO2000032606A1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM
06/08/2000WO2000032599A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/08/2000WO2000032590A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
06/08/2000WO2000023446A8 Core-extended perylene bisimides and the use thereof as fluorescent dyes
06/08/2000WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose
06/08/2000CA2351062A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/07/2000EP1006115A2 Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
06/07/2000EP1005468A1 Antibiotic oxazolidinone derivatives
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 646